Inotiv (NOTV) to Release Earnings on Friday

Inotiv (NASDAQ:NOTVGet Free Report) is set to announce its earnings results before the market opens on Friday, May 10th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Inotiv (NASDAQ:NOTVGet Free Report) last posted its earnings results on Wednesday, February 7th. The company reported ($0.60) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.67). Inotiv had a negative net margin of 5.67% and a negative return on equity of 10.99%. The business had revenue of $135.50 million during the quarter, compared to analysts’ expectations of $136.26 million. On average, analysts expect Inotiv to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inotiv Trading Down 1.3 %

NOTV stock opened at $4.71 on Wednesday. The firm has a market cap of $121.47 million, a PE ratio of -3.62 and a beta of 3.37. The firm has a fifty day moving average price of $7.26 and a 200 day moving average price of $4.72. Inotiv has a fifty-two week low of $1.61 and a fifty-two week high of $11.42. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.28 and a current ratio of 1.74.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Inotiv from a “hold” rating to a “buy” rating and raised their price target for the stock from $3.00 to $11.50 in a research report on Friday, February 9th.

Read Our Latest Stock Report on Inotiv

Inotiv Company Profile

(Get Free Report)

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.

See Also

Earnings History for Inotiv (NASDAQ:NOTV)

Receive News & Ratings for Inotiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inotiv and related companies with MarketBeat.com's FREE daily email newsletter.